NCT07341139

Brief Summary

The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions:

  1. 1.The effect of blood storage time on the patient's 28-day mortality rate.
  2. 2.The relationship between storage time and other health problems that the patient may develop (such as heart disease, vascular occlusion, respiratory failure, infection, and organ failure).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

December 17, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

January 17, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

December 17, 2025

Last Update Submit

February 12, 2026

Conditions

Keywords

blood storageTransfusionTraumaRed Blood Cell

Outcome Measures

Primary Outcomes (1)

  • 28-day Mortality

    The aim of this study was to evaluate the effect of red blood cell and whole blood storage duration on 28-day mortality in severely injured trauma patients (injury severity score \>15) undergoing massive transfusion.

    At the day of 28 after massive blood transfusion

Secondary Outcomes (5)

  • 28-day Morbidity - Cardiac Ischemia

    At the day of 28 after massive blood transfusion

  • 28-day morbidity- thromboembolic events

    At the day of 28 after massive blood transfusion

  • 28-day morbidity- nosocomial infection

    At the day of 28 after massive blood transfusion

  • 28-day morbidity- multiple organ failure

    At the day of 28 after massive blood transfusion

  • 28-day morbidity- acute respiratory failure

    At the day of 28 after massive blood transfusion

Study Arms (1)

Group 1

The study will include patients aged 18-75, with an ISS \>15, who presented directly from the injury scene and received massive transfusion (defined as \>10 packed RBC (PRBC) units in the first 24 hours or ≥3 units in 1 hour) between January 1, 2023, and October 1, 2025. Data will be extracted from hospital information systems and anesthesia records. The storage duration for each transfused unit (from collection to transfusion) will be recorded.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In our study, patients between the ages of 18-75, directly from the scene of injury, ISS\>15 and who received massive blood transfusion (\>10 packed RBC units in the first 24 hours, with an alternative definition of greater than or equal to 3 packed RBC units transfused in 1 hour) will be included in the study at University of Florida Jacksonville Shands Hospital between the dates 1 January 2023 to 1 31 December 2025.

You may qualify if:

  • Patients between 18-75 years of age,
  • Injury Severity Score\>15 and have received massive blood transfusions in our hospital from 1 January 2015 to 31 December 2025
  • The patients admitted because of trauma and undergoing surgery

You may not qualify if:

  • Patients with known cardiac or vascular diseases such as heart failure or malignant hypertension, those under anticoagulant treatment
  • Patients with known serious kidney (on dialysis), lung, liver diseases, those under anticoagulant treatment
  • Super obese patients with body mass index (BMI) 50 or above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health Jacksonville (Shands Hospital)

Jacksonville, Florida, 32209, United States

RECRUITING

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • ayten saracoglu

    University of Florida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

ayten saracoglu, prof dr

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2025

First Posted

January 14, 2026

Study Start

January 17, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations